FDA
-
-
-
-
-
-
-
Mylan (MYL) and Fujifilm Kyowa Kirin Biologics Announce U.S. FDA Approval of Hulio
-
-
-
-
-
-
-
Mapi Pharma and Mylan Strengthen Partnership to Develop and Commercialize Once-Monthly Glatiramer Acetate Depot for Relapsing-Remitting Forms of Multiple Sclerosis
-
-
-
-
-
-
-
Mylan to Supply Investigational Antiviral Remdesivir for the Potential Treatment of COVID-19
-
-
-
-
-
-
-
Mylan Ramps Up U.S. Manufacturing of Hydroxychloroquine Sulfate Tablets to Meet Potential COVID-19 Patient Needs
-
-
-
-
-
-
-
Mylan Initiates Voluntary Nationwide Recall of Three Lots of Nizatidine Capsules, USP, Due to the Detection of Trace Amounts of NDMA (N-Nitrosodimethylamine) Impurity Found in the Active Pharmaceutica
-
-
-
-
-
-
-
Mylan (MYL) Expands Oncology Portfolio with Launch of Generic Faslodex Injection
-
-
-
-
-
-
-
Mylan (MYL) Receives FDA ANDA Approval for Scopolamine 1MG/72HR
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

